Surgery for liver metastases from pancreatic cancer
Part of Cancer clinical trials.
This trial studies outcomes of surgery (and sometimes heating/cutting techniques) for pancreatic cancer that has spread only to the liver. It’s for people whose liver tumors can potentially be removed with curative intent, aiming to improve long-term results after local treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed pancreatic ductal adenocarcinoma (PDAC) and it has spread only in the liver (and, in some cases, limited other sites as judged suitable for cure).
- Your liver involvement is limited: up to 4 liver metastases, with sizes small enough for surgery or ablation (heating) (largest <5 cm; for ablation <2 cm).
- You are 18 or older and can understand study information (verbal and written).
- Your general health is good enough (ECOG 0–1), and the cancer is considered suitable for removal without needing artery reconstruction.
- You did not have tumor growth on scans during or after chemotherapy, and you don’t have cancer spread beyond the liver (for the main group).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares surgery to remove the primary tumor and up to 3 liver spots against standard palliative care for people with pancreatic cancer that has spread only to the liver (up to 3 spots). It is for those whose cancer has not grown after initial chemotherapy and who are healthy enough for surgery.
This trial is for people with pancreatic cancer that has spread to the liver (3 spots or fewer). It tests whether removing both the original tumor and the liver spots after a specific chemotherapy (FOLFIRINOX) can be helpful. You may be eligible if the chemo shrinks the tumors enough and you are healthy enough for surgery.
This trial tests whether removing or ablating limited liver or lung tumors from pancreatic cancer that has not spread elsewhere, along with a specific chemotherapy (NALIRIFOX), can help patients. It is for people who have not had any previous cancer treatment.
This study tests advanced treatments for cancer that has spread to the liver, either from colon cancer or pancreatic cancer. It may help by targeting liver tumors using treatment plans and, for some participants, liver tissue samples.
This study tests a new treatment combining tumor destruction with heat/cold (ablation) and an immunotherapy drug (PD-1) for people whose pancreatic cancer has spread to the liver. The goal is to help the immune system fight the cancer better.
This trial tests whether combining local treatments (like radiation or surgery) with standard care can help people with pancreatic cancer that has spread to only a few spots (oligometastatic disease). The goal is to improve outcomes for this specific group of patients.
Hear when a new Disseminated Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.